Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunosuppressive Agents | 8 | 2008 | 384 | 0.850 |
Why?
|
| Kidney Transplantation | 7 | 2006 | 330 | 0.620 |
Why?
|
| Lupus Nephritis | 2 | 2011 | 37 | 0.580 |
Why?
|
| Vasculitis | 2 | 2008 | 50 | 0.510 |
Why?
|
| Autoimmune Diseases | 2 | 2010 | 242 | 0.470 |
Why?
|
| Kidney Failure, Chronic | 4 | 2006 | 205 | 0.320 |
Why?
|
| Calcitonin | 1 | 2010 | 17 | 0.310 |
Why?
|
| Protein Precursors | 1 | 2010 | 85 | 0.310 |
Why?
|
| Amaurosis Fugax | 1 | 2008 | 1 | 0.290 |
Why?
|
| Temporal Arteries | 1 | 2008 | 5 | 0.290 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2008 | 10 | 0.290 |
Why?
|
| Coronary Vasospasm | 1 | 2008 | 11 | 0.290 |
Why?
|
| Kidney Diseases | 2 | 2006 | 180 | 0.280 |
Why?
|
| Mevalonic Acid | 1 | 2007 | 4 | 0.260 |
Why?
|
| Gadolinium | 1 | 2008 | 110 | 0.260 |
Why?
|
| Angioedema | 1 | 2006 | 10 | 0.250 |
Why?
|
| Diabetes Mellitus | 2 | 2011 | 555 | 0.240 |
Why?
|
| Sirolimus | 1 | 2006 | 93 | 0.240 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 143 | 0.240 |
Why?
|
| Troponin T | 1 | 2005 | 24 | 0.230 |
Why?
|
| Troponin I | 1 | 2005 | 36 | 0.230 |
Why?
|
| Coronary Disease | 1 | 2005 | 248 | 0.210 |
Why?
|
| Pneumonia | 1 | 2006 | 293 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 1 | 2005 | 877 | 0.170 |
Why?
|
| Humans | 18 | 2011 | 65554 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2006 | 466 | 0.110 |
Why?
|
| Blood Pressure | 3 | 2005 | 526 | 0.110 |
Why?
|
| Biomarkers | 2 | 2010 | 1473 | 0.090 |
Why?
|
| Prognosis | 2 | 2005 | 1793 | 0.080 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2010 | 11 | 0.080 |
Why?
|
| Giant Cell Arteritis | 1 | 2010 | 6 | 0.080 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2010 | 8 | 0.080 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2010 | 26 | 0.080 |
Why?
|
| Kidney | 3 | 2005 | 456 | 0.070 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2010 | 172 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2006 | 473 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 998 | 0.070 |
Why?
|
| Adult | 7 | 2011 | 17417 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2011 | 413 | 0.070 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2007 | 1 | 0.070 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 122 | 0.070 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2007 | 14 | 0.070 |
Why?
|
| Diphosphonates | 1 | 2007 | 33 | 0.060 |
Why?
|
| Graft Rejection | 2 | 2006 | 302 | 0.060 |
Why?
|
| Biopsy | 1 | 2008 | 457 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 46 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1114 | 0.060 |
Why?
|
| Polycystic Kidney Diseases | 1 | 2006 | 20 | 0.060 |
Why?
|
| Pyrroles | 1 | 2006 | 52 | 0.060 |
Why?
|
| Eye Infections | 1 | 2006 | 3 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 91 | 0.060 |
Why?
|
| Indoles | 1 | 2006 | 119 | 0.060 |
Why?
|
| Heart Rate | 2 | 2005 | 331 | 0.060 |
Why?
|
| Chromans | 1 | 2005 | 16 | 0.060 |
Why?
|
| Uveitis | 1 | 2006 | 35 | 0.060 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 344 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1575 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2008 | 151 | 0.060 |
Why?
|
| CD52 Antigen | 1 | 2005 | 4 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2006 | 164 | 0.060 |
Why?
|
| Antigens, CD20 | 1 | 2005 | 14 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2005 | 54 | 0.060 |
Why?
|
| Thiazolidinediones | 1 | 2005 | 50 | 0.060 |
Why?
|
| CTLA-4 Antigen | 1 | 2005 | 73 | 0.060 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 71 | 0.060 |
Why?
|
| Syndrome | 1 | 2005 | 182 | 0.060 |
Why?
|
| Plasma Exchange | 1 | 2005 | 24 | 0.060 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2005 | 38 | 0.060 |
Why?
|
| Infliximab | 1 | 2005 | 50 | 0.060 |
Why?
|
| PPAR gamma | 1 | 2005 | 77 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2005 | 158 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 142 | 0.060 |
Why?
|
| Contrast Media | 1 | 2008 | 433 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 2006 | 92 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 215 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 182 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2005 | 151 | 0.060 |
Why?
|
| Cyclosporine | 1 | 2005 | 77 | 0.060 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 135 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2007 | 682 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 375 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2005 | 189 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2005 | 349 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2005 | 109 | 0.050 |
Why?
|
| Skin Diseases | 1 | 2005 | 83 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 175 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2005 | 292 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 661 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2005 | 224 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 757 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 623 | 0.050 |
Why?
|
| Female | 6 | 2011 | 34131 | 0.050 |
Why?
|
| Renal Dialysis | 1 | 2003 | 195 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2005 | 390 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 924 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 801 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1012 | 0.040 |
Why?
|
| Animals | 3 | 2008 | 21533 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2006 | 5822 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 2632 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 2248 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2005 | 3355 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 866 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2006 | 178 | 0.030 |
Why?
|
| Mice | 1 | 2008 | 11209 | 0.030 |
Why?
|
| Aorta | 2 | 2005 | 114 | 0.030 |
Why?
|
| Aged | 1 | 2005 | 14958 | 0.020 |
Why?
|
| Male | 5 | 2006 | 31083 | 0.020 |
Why?
|
| Leukemia, Myeloid | 1 | 2006 | 36 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 2006 | 22 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2006 | 36 | 0.020 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2006 | 21 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2006 | 61 | 0.020 |
Why?
|
| Romania | 1 | 2006 | 2 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2005 | 131 | 0.010 |
Why?
|
| Medical Records | 1 | 2006 | 139 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 249 | 0.010 |
Why?
|
| Wakefulness | 1 | 2005 | 44 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 134 | 0.010 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2005 | 43 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 457 | 0.010 |
Why?
|
| Gingival Hyperplasia | 1 | 2005 | 3 | 0.010 |
Why?
|
| Candidiasis, Oral | 1 | 2005 | 6 | 0.010 |
Why?
|
| Hypertrichosis | 1 | 2005 | 4 | 0.010 |
Why?
|
| Hyperpigmentation | 1 | 2005 | 6 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2006 | 155 | 0.010 |
Why?
|
| Erythema | 1 | 2005 | 12 | 0.010 |
Why?
|
| Skin Diseases, Infectious | 1 | 2005 | 12 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2005 | 15 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 376 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2005 | 200 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2005 | 257 | 0.010 |
Why?
|
| Adolescent | 2 | 2006 | 6377 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2006 | 190 | 0.010 |
Why?
|
| Living Donors | 1 | 2003 | 79 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2006 | 6884 | 0.010 |
Why?
|
| Sleep | 1 | 2005 | 240 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 1613 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 1218 | 0.010 |
Why?
|
| Family | 1 | 2003 | 247 | 0.010 |
Why?
|
| Echocardiography | 1 | 2003 | 512 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 2510 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 720 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 821 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 3788 | 0.010 |
Why?
|
| Middle Aged | 2 | 2006 | 18277 | 0.010 |
Why?
|